-
Future Innovative Radionuclides for Cancer Treatment at INFN
Founded in 1951, the Italian Institute for Nuclear Physics (INFN) is the public research institute that has taken up the scientific legacy of Enrico Fermi and, for more than seventy years, it conducted cutting-edge research in the field of nuclear, particle, and astroparticle physics, as well as in developing technologies for research and their applications…
-
Uso dei Radiofarmaci terapeutici: pubblicato lo studio SAMIRA
La Commissione Europea ha pubblicato lo studio SAMIRA, “SAMIRA study on the implementation of the Euratom and EU legal bases with respect to the therapeutic uses of radiopharmaceuticals” che analizza le difficoltà nell’applicazione delle normative UE e Euratom sull’uso terapeutico dei radiofarmaci, fondamentali nella medicina nucleare, soprattutto oncologica. Il progetto SIMPLERAD ha individuato barriere normative,…
